Retinoic Acid Receptor Alpha
Showing 1 - 25 of >10,000
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- SY-1425 (tamibarotene)
- +2 more
-
Hartford, Connecticut
- +25 more
May 4, 2022
Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)
Not yet recruiting
- Depressive Disorder, Major
- +2 more
- Ketamine
- +2 more
-
New Haven, ConnecticutYale University
Jun 26, 2023
Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)
Recruiting
- Depressive Disorder, Major
- +2 more
- Ketamine
- +2 more
-
New Haven, ConnecticutYale University
Aug 8, 2022
Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)
Recruiting
- Acute Promyelocytic Leukemia
- +2 more
-
Beijing, Beijing, ChinaPeking University Institute of Hematology
Apr 26, 2023
Fibrodysplasia Ossificans Progressiva Trial in Paris (Palovarotene)
Completed
- Fibrodysplasia Ossificans Progressiva
-
Paris, FranceHôpital Necker-Enfants Malades, Department of Genetics
Jul 28, 2022
MDS Trial in Worldwide (Tamibarotene + Azacitidine, Tamibarotene Matched Placebo + Azacitidine)
Recruiting
- Myelodysplastic Syndromes
- Tamibarotene + Azacitidine
- Tamibarotene Matched Placebo + Azacitidine
-
Tucson, Arizona
- +87 more
Feb 2, 2023
Male Infertility, Azoospermia Trial in Seattle (13-cis retinoic acid)
Completed
- Male Infertility, Azoospermia
- 13-cis retinoic acid
-
Seattle, WashingtonUniversity of Washington Medical Center
Sep 27, 2021
Male Infertility, Klinefelter's Syndrome, Y-chromosome Microdeletions Trial in Seattle (13-cis retinoic acid, Calcitriol)
Completed
- Male Infertility
- +2 more
- 13-cis retinoic acid
- Calcitriol
-
Seattle, WashingtonUniversity of Washington Medical Center
Jul 29, 2021
Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)
Active, not recruiting
- Triple -Negative Breast Cancer
- +4 more
- Biopsy
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Aug 1, 2022
Scalp Psoriasis Trial in Karachi (Tazarotene 0.045% Topical Application Lotion [ARAZLO])
Completed
- Scalp Psoriasis
- Tazarotene 0.045% Topical Application Lotion [ARAZLO]
-
Karachi, Sindh, PakistanJPMC
Aug 28, 2023
Leukemia Trial in Chicago, Kankakee (recombinant interferon alfa, amifostine trihydrate, bromodeoxyuridine)
Withdrawn
- Leukemia
- recombinant interferon alfa
- +7 more
-
Chicago, Illinois
- +3 more
Oct 6, 2021
Drug Toxicity, Lung Cancer Trial in Denver (13-cis retinoic acid, Tocopherol)
Completed
- Drug Toxicity
- Lung Cancer
- 13-cis retinoic acid
- Tocopherol
-
Denver, Colorado
- +3 more
May 13, 2020
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)
Active, not recruiting
- BRCA1 Gene Mutation
- +9 more
- Laboratory Biomarker Analysis
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 16, 2022
Melanoma Trial in Aurora (VESANOID, Ipilimumab)
Active, not recruiting
- Melanoma
-
Aurora, ColoradoUniversity of Colorado Hospital
Sep 7, 2022
Post COVID-19 Anosmia (Loss of Smell) Trial in Foshan, Kafr Ash Shaykh, Riyadh (Aerosolized 13 cis retinoic acid plus Vitamin D,
Not yet recruiting
- Post COVID-19 Anosmia (Loss of Smell)
- Aerosolized 13 cis retinoic acid plus Vitamin D
- +2 more
-
Foshan, Guangdong, China
- +2 more
Nov 9, 2021
Obesity, Inflammation Trial in Madison (Yogurt, Control food)
Completed
- Obesity
- Inflammation
- Yogurt
- Control food
-
Madison, WisconsinDepartment of Food Science, Babcock Hall
Nov 15, 2022
Acne Vulgaris Trial in Dripping Springs, Pflugerville (Isotretinoin, Amzeeq 4% Topical Foam)
Active, not recruiting
- Acne Vulgaris
- Isotretinoin
- Amzeeq 4% Topical Foam
-
Dripping Springs, Texas
- +1 more
Mar 22, 2022
Kidney Cancer Trial in New York (recombinant interferon alfa, tretinoin liposome)
Completed
- Kidney Cancer
- recombinant interferon alfa
- tretinoin liposome
-
New York, New York
- +1 more
Mar 17, 2022
Tuberculosis Trial in Cairo, Riyadh (13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB), 9 cis retinoic
Not yet recruiting
- Tuberculosis
- 13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB)
- +5 more
-
Cairo, Kafr El-sheikh, Egypt
- +1 more
Oct 11, 2021
CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)
Not yet recruiting
- CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
- +3 more
- (no location specified)
Nov 14, 2022
COVID19 Trial in Cairo (Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment, Isotretinoin(Aerosolized 13 cis
Not yet recruiting
- COVID19
- Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment
- +4 more
-
Cairo, Kafr El-sheikh, Egypt
- +1 more
Jul 29, 2021
Depressive Disorder, MDD, Bipolar Disorder Trial in West Haven (Perampanel 6 MG, Ketamine, Placebo)
Not yet recruiting
- Depressive Disorder
- +4 more
- Perampanel 6 MG
- +2 more
-
West Haven, ConnecticutVA Connecticut Healthcare System
Mar 14, 2023